Author
Rohinton Edalji
Also Known As
R Edalji, R P Edalji, R. Edalji, R. P. Edalji, R.P. Edalji, Rohinton Edalji, Rohinton P. Edalji
55
Publications
3.3K
Citations
26
H-Index
85
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 22 | 26 | 2.3K |
2 | Natural Sciences | 16 | 17 | 1.1K |
3 | Engineering | 3 | 3 | 158 |
4 | Health Sciences | 1 | 1 | 26 |
5 | Allergy | 1 | 1 | 65 |
Rohinton Edalji
×
39
Publications
3.3K
Citations
26
H-Index
| Year | Citations | |
|---|---|---|
2017 | 813 | |
2009 | 352 | |
1991 | 192 | |
Discovery of <i>N</i>-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor | 2017 | 133 |
2018 | 133 | |
1990 | 119 | |
1989 | 119 | |
1975 | 115 | |
1998 | 109 | |
1997 | 87 |
Page 1
Page 1